If you haven`t bought ARDS before it went up 6X: Then analyzing the options chain and the chart patterns of ARDX Ardelyx prior to the earnings report this week, I would consider purchasing the 4usd strike price Calls with an expiration date of 2024-1-19, for a premium of approximately $0.45. If these options prove to be profitable prior to the earnings release,...
ARDX Ardelyx is a biopharmaceutical company that discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the US and internationally. On 3/2/2022 Jefferies Financial Group Upgraded ARDX from Hold to Buy raising the price target from $1.00 to $5.00 This would be a 581% gain from the current level. Looking...
in at 4.03 lets see if this wild undisciplined bull runs
NASDAQ:ARDX If it passes the bearish line it's time for a short position, and if it passes the bullish line it's time for the Long position, the price targets are on the chart.
ARDX A strong opportunity to buy a company's stock It may drop more, do not be afraid, it is a second opportunity to buy, I cannot determine the time when the company’s stock will rise, this is only known to the market maker, for this patience is important in trading a company’s stock I'm honored that you follow me on Tradingview ARDX
I think the ChART is about to explode north! Falling Wedge. Finding support on the descending diagonal inside the falling wedge. Bouncing inside channels on RSI & RSI divergence indicators.
With a bullish cross on the 50/200 on the 3 hr time frame. Above the 20 week. Continuation to the upside is in the works. Add here!
This trade is not actionable without volume confirmation, wedge breakout, and ofc a SET SL AND TP ALSO looking at GAP fill over $2.00+
Laying it down... TNXP DJI BTC ITRM THMO QLGN CLOV ARDX NAKD @dRends35 this one is for you my friend across the pond!
This is why I took a small profit to make sure there was no large pullback. But it held the 20 WMA. Held RSI support. I'm back in...
Ardelyx , Inc. ARDX had one of the the highest the out of the money call options, due to the fact they plan to launch IBSRELA, the company's FDA approved treatment for irritable bowel syndrome with constipation (IBS-C) in adults, in the second quarter of 2022, that has a potential peak in revenue greater than 500mil per year. Since ARDX’s Market Cap is only...
MM's could shake out the paper hands. I'm taking small profits to see what happens next. Let's see if this extended hours falling wedge plays out.
I have researched where to put my money. I've switched a couple of times as the markets have changed. One thing I have noticed is that the BioPharmaceutical, Pharmaceutical, BioTech, and a SPAC thrown into the mix for good measure were all in the same exact pattern. They all have been heavily shorted since Feb 2021... They are all down 80-90% over the year....
Where's the Alpha? Where am I at in these markets? BioFink lives!
These ChARTs are amazing! All in a similar setup. This first target is epic! $27 in play from this falling wedge. Fink is back in 6... TNXP, ITRM, THMO, ARDX, CLOV, & QLGN... BIOTECH and a Healthcare SPAC! DELTA - OMNICRON... I saw the anagram as soon as they posted that name after DELTA. MEDIA-CON(N)TROL... SAME as COVID... It's all in front of...
Ardelyx, Inc. ARDX yesterday had one of the the highest the out of the money call options, due to the fact they plan to launch IBSRELA, the company's FDA approved treatment for irritable bowel syndrome with constipation (IBS-C) in adults, in the second quarter of 2022, that has a potential peak in revenue greater than 500mil per year. Since ARDX’s Market Cap is...
These ChARTs look like they wanna skyrocket. 3 Week Confirmed Bullish Divergence. Engulfing to close tomorrow. 30x is possible and probable.
The FDA is unlikely to approve Ardelyx`s drug for dialysis patients. Ardelyx received a letter from the FDA stating that deficiencies in the information provided had been found that would preclude discussion of approvals Ardelyx has sought. The most likely target is the 1.6usd support line from which it can bounce up.